113
Participants
Start Date
November 30, 2004
Primary Completion Date
March 31, 2006
Combivent® CFC MDI
Albuterol HFA MDI
620 South 20th Street, NHB 104, Birmingham
Cooper Green Hospital, Birmingham
Southern California Clinical Trials, Lakewood
Boehringer Ingelheim Investigational Site, Palmdale
Boehringer Ingelheim Investigational Site, Wheat Ridge
Norwalk Hospital, Norwalk
University of Miami School of Medicine, Miami
Boehringer Ingelheim Investigational Site, Panama City
Boehringer Ingelheim Investigational Site, Coeur d'Arlene
Boehringer Ingelheim Investigational Site, River Forest
Boehringer Ingelheim Investigational Site, Olathe
LSU MC-Sheveport, Shreveport
Boehringer Ingelheim Investigational Site, Auburn
Johns Hopkins Asthma & Allergy, Baltimore
Brigham & Women's Hospital, Boston
Boehringer Ingelheim Investigational Site, Berlin
Boehringer Ingelheim Investigational Site, Cherry Hill
North Shore University Hospital, Manhasset
NYU School of Medicine, New York
Division of Pulmonary & Critical Care Medicine, Durham
Wake Forest University, Center for Human Genomics, Winston-Salem
Penn State University, Hershey Medical Center, Hershey
Boehringer Ingelheim Investigational Site, Charleston
Spartanburg Medical Research, Spartanburg
Ben Taul General Hospital, Houston
University of Texas Health Center at Tyler, Tyler
University of Wisconsin Hospital, Madison
Lead Sponsor
Boehringer Ingelheim
INDUSTRY